Why Is the New York Times Laundering the Reputation of a Sleazy AI Startup That's Selling GLP-1s via a Dishonest Dumpster Fire of Fake Doctors, Phony Before-and-After Pictures, a Warning From the FDA, and Other Glaring Red Flags?

"The New York Times described Medvi as a $1.8 billion company with just two employees, suggesting that in the age of AI, such feats are increasingly achievable. However, previous investigations into Medvi revealed a more disturbing reality, including misleading advertisements and questionable practices that cast doubt on the company's legitimacy."

"Medvi's website promised visitors the ability to 'lose 40 pounds by July with GLP-1 medication,' showcasing AI-generated before-and-after photos and testimonials. This raised red flags about the authenticity of the claims and the ethical implications of using AI in such a sensitive industry."

Medvi, a pharmaceutical company led by Matthew Gallagher, is projected to achieve nearly $2 billion in sales this year while employing only two people. The New York Times praised this achievement as indicative of a new business era. However, previous investigations revealed troubling aspects of Medvi, including misleading advertising and questionable practices. The company's website featured AI-generated images and dubious testimonials, raising concerns about its authenticity and ethical standards in the pharmaceutical industry.

Read at Futurism